Tag: Daniel Kim
Samsung Biologics set to acquire PolyPeptide for USD1.8bn
Firms act on Samsung Biologics’ proposed CHF1.46 billion (USD1.8 billion) acquisition of Switzerland-based PolyPeptide Group
O’Melveny, Goodwin, White & Case in Samsung-eMagin merger
Three firms counsel Samsung Display and NYSE-listed eMagin in an agreement for the subsidiary of Samsung Electronics specialising in display products to acquire the American company for a USD218 million cash merger
O’Melveny helps SK invest in ammonia energy startup
O’Melveny assisted SK Innovation, an intermediate holding company of South Korean conglomerate SK Group, in its USD30 million investment in Amogy, a US company specialising in ammonia-based fuel cell systems
Indonesia’s top 100 lawyers 2022
After experiencing its first economic contraction in two decades, Indonesia’s strong rebound was interrupted by the spreading delta variant of covid-19 in 2021
